Latest Breaking News On - Potentially deadly cancer facing median survival - Page 1 : comparemela.com

/PRNewswire/ Atara Biotherapeutics, Inc. (Nasdaq: ATRA), and Pierre Fabre today announced that the European Commission (EC) has granted marketing.

Midi pyréesUnited statesPierre fabreEric hyllengrenEric ducournauLaure sgandurraPascal touchonAtara biotherapeutics incEuropean commissionEuropean unionEuropean medicines agencyCommittee for medicinal products human usePierre fabre health carePierre fabre foundationOnly approved therapyPotentially deadly cancer facing median survival